# Donald P. Lawrence

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/donald-p-lawrence/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,455 |
| Field | Melanoma and MAPK Pathways |
| h-index | 67 |
| i10-index | 135 |
| Last Known Institution | Massachusetts General Hospital |
| OpenAlex ID | https://openalex.org/A5049839632 |
| ORCID iD | https://orcid.org/0000-0001-5288-9110 |
| Works | 420 |

## Researcher papers

- [Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)](https://scholariq.org/papers/cutaneous-keratoacanthomas-squamous-cell-carcinomas-associated-with/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.